Northera droxidopa: Phase II ongoing

An independent DMC recommended continuation of enrollment in 7 of 12 arms of a double-blind, U.K. Phase II trial. Enrollment will continue in cohorts receiving 50 mg oral carbidopa; 600 mg oral droxid...